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Iron overload is a major cause of morbidity and mortality in some diseases such as beta thalassemia. 
Conventional therapies with phlebotomy and iron chelating agents have shown no profound effect on iron 
excessive disease. Moreover, hepcidin as an iron transport inhibitor can absorb more iron than normal level 
following overexpression in macrophages. For this purpose, We hypothised that repeat transplantation of 
manipulated macrophages and their replacement, can remove the excess iron and decrease iron toxicity, a 
process that is called, spongious therapy. 
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Introduction 
Iron is a bio-metal agent that is essential for many 
biological processes [1, 2]. Because of its ability to oxidation 
and reduction readily by switching between ferric (Fe3+) and 
ferrous (Fe2+) states, iron is a key component of many 
proteins such as hemoglobin, myoglobin and mitochondrial 
electron transport chain enzymes [1, 2]. Following absorption, 
iron combines with iron transporting protein, called 
transferrin, and then enters the intracellular pool, mostly as a 
ferritin form in macrophages of the reticuloendothelial system 
and/or a complex with hemoglobin in red blood cells [1]. There 
is no excretory mechanism for iron, and its level is only 
controlled via absorption [3, 4]. Therefore, iron can be easily 
accumulated following conditions that induce iron storage [3, 
5].  
Iron overload means the accumulation of excess iron in the 
body due to primary and secondary causes [6]. The well-known 
example of primary iron overload is the hereditary 
hemochromatosis in which the intestinal iron absorption is 
increased [3]. Thalassemia major, sideroblastic anemia and 
chronic liver diseases represent the common causes of 
secondary iron overload [3]. As iron overload has toxic effects, 
it can promote diabetes, cardiomyopathy, hepatocellular 
carcinoma, arthritis, hypogonadism, cirrhosis, osteoporosis 
and fractures [7-9].  
HYPOTHESIS 
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Iron overload can be treated with phlebotomy and iron 
chelators [9]. But in severe conditions such as thalassemia, 
these therapies cannot prevent iron overload complications. 
For this reason, it is also the major cause of morbidity and 
mortality in patients with beta thalassemia [9, 10].  
Hypothesis 
We hypothesed that the excessive iron would be absorbed 
by engrafting the manipulated macrophages into the bone 
marrow cavity. Following leukocyte collection from 
peripheral blood of patients by leukopheresis, monocytes are 
easily separated from the other leukocytes by density gradient 
centrifugation using Nycoprep 1.068. Then, in the presence of 
the human serum for 7-10 days, the monocytes are 
differentiated to the macrophages [11]. It has been already 
found that the hipcidin hormone inhibits iron transport out of 
macrophages by inducing ferroportin internalization and 
degradation [12, 13]. So, upon overexpression of hipcidin in 
macrophages, these manipulated cells are able to absorb iron 
greater than normal level. Finally, these cells can be infused 
into the medullary cavity of the femur and tibia (spongious 
therapy) and refreshed by the novel (unloaded) cells following 
overloading with Iron. 
Evaluation of the hypothesis 
There are different methods to evaluate the iron status of 
the body. The easiest and most straightforward technique is 
the evaluation of the blood iron level. Total iron binding 
capacity (TIBC), transferrin iron saturation, free unbound iron 
and specially ferritin are the most important serum iron 
indexes. Moreover, tissue storage of iron can be calculated by 
the Perls' Prussian blue staining of the bone marrow aspirate. 
Long-term follow-up after spongious therapy can be achieved 
by the survival rate of chronically transfused patients. 
Refreshing time for overloaded macrophage depends on the 
iron rate of the target bone marrow and in vivo longevity of 
these cells. 
Discussion 
This hypothesis shows several strong points, if be 
confirmed. 1) The graft can be easily achieved by the 
phlebotomy method without any aggressive intention. 2) 
Autologous transplantation will hinder the adverse 
immunologic reactions. 3) The natural body mechanisms and 
materials are employed to differentiation of the monocytes 
into the macrophages. 4) Because of lack of the lymph vessel 
in the bone cavity, the macrophages cannot leave this tissue 
and diffuse to the other organs. This leads to the accumulation 
of macrophages in the distinct area and allows them to be 
exchangeable. 5) On the other hand, due to the existence of 
Figure 1. Schematic representation of the hypothesis design. Briefly, the patient 
monocytes are differentiated to the macrophages and infused into the medullary cavity of the 
femur and tibia (spongious therapy) followed by hepcidin overexpression and finally, refreshed 
by the novel (unloaded) manipulated cells. 
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blood vessel in bone cavity, the transplanted cells have access 
to the blood nutrients, oxygen and especially iron. 
Manipulation of macrophages allows removing more iron 
than normal. Although the natural mechanisms are involved in 
this process, concern of cancer development may arise 
because of the manipulation and distance away from their 
native niche. However, the long-term in vivo and in vitro study 
should be proposed to assess the transformation and 
malignancy potency of manipulated cells. 
We adopted "spongious therapy" terminology, because the 
macrophages absorb the body excess iron and then these cells 
are periodically exchanged with the new ones, like sponge.  
Besides iron overload therapy, spongious therapy can be used 
for treatment of the diseases associated with the excessive 
substances such as the lipidemia and gamma globulinemia. 
However, the autologous macrophages can remove the excess 
element and then are exchanged without any unwanted side 
effects. 
Conclusions 
Because of absorbent properties of manipulated 
macrophages, spongious therapy can be used for treatment of 
iron overload. It is expected that this therapy will decrease the 
iron storage of the patients with the overloaded iron, and 
increase their survival rate. 
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